Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588471 · ClinicalTrials.gov registry record · NA
Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT00588471: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT00588471 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588471, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
The goal of this study is to determine if one dose of simvastatin will decrease the inflammatory response to coronary intervention. Also to determine if one dose of simvastatin affects endothelial function (activity of the artery) as measured by noninvasive peripheral artery tonography.
Interventions
- DRUG Placebo
- DRUG Simvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2002-11 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588471
The ClinicalTrials.gov registry entry for NCT00588471 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00588471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588471 about?
NCT00588471 is a clinical study titled "Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention". The goal of this study is to determine if one dose of simvastatin will decrease the inflammatory response to coronary intervention. Also to determine if one dose of simvastatin affects endothelial function (activity of the artery) as measured by noninvasive peripheral artery tonography.
What is the current status of trial NCT00588471?
This trial is currently terminated. It is a NA study. The enrollment target is 57 participants. The study started on 2002-11. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00588471?
The interventions under investigation include: Placebo (DRUG), Simvastatin (DRUG).
Who is sponsoring clinical trial NCT00588471?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.